Mandate

Nordstjernan invests in Mama Mia

December 20, 2017 M&A

Vinge has advised Nordstjernan in conjunction with the acquisition of the majority of shares in Barnmorskegruppen MAMA MIA Aktiebolag (”Mama Mia”), as a supplementary acquisition to Lideta Hälsovård.

Mama Mia conducts prenatal and childcare services at seven units in Stockholm and Malmö, as well as primary care at two units in Stockholm under the trademark, To Care. The company has grown quickly over the last few years and during the last financial year its turnover was approximately MSEK 200 with approximately 170 employees.

Vinge’s team consisted of Johan Winnerblad, Kristina Ekberg, Samra Baytar, Josephine Andersson, Martin Boström, Frida Ställborn and Mikaela Lang.
 

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024